DMAC DiaMedica Therapeutics Inc.

3.54
+0.14  (+4%)
Previous Close 3.4
Open 3.41
Price To Book 30.34
Market Cap 27813338
Shares 7,856,875
Volume 78,131
Short Ratio
Av. Daily Volume 122,640

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 2 data due 4Q 2019 or 1Q 2020.
DM199 - Remedy
Acute ischaemic stroke
Phase 2 trial to be initiated 2019/2020.
DM199
Vascular dementia
Phase 2 trial to be initiated late 2018 or 1H 2019 with data due 2H 2019.
DM199
Chronic Kidney Disease